美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

信息服務

5.75

+0.09001.59%

盤後：5.64-0.1100-1.91%19:20 EDT

成交量：19.35萬

成交額：110.21萬

市值：2.77億

市盈率：36.64

高：5.78

開：5.67

低：5.64

收：5.66

52周最高：6.01

52周最低：2.95

股本：4,819.55萬

流通股本：3,423.30萬

量比：0.66

換手率：0.57%

股息：0.18

股息率：3.13%

每股收益(TTM):0.1569

每股收益(LYR):0.0582

淨資產收益率：8.29%

總資產收益率：3.59%

市淨率：2.95

市盈率(LYR):98.81

資料載入中...

總覽公司新聞公告

新股消息 | 濱會生物遞表港交所已將BS001推進至中國黑色素瘤III期臨牀試驗

銀諾醫藥-B(02591)已在中國完成核心產品(即依蘇帕格魯肽α)用於治療肥胖和超重的III期臨牀試驗的首例患者給藥

港股異動 | 醫渡科技(02158)漲超14% AI有望賦能臨牀試驗附屬中標SMR001滴眼液III期臨牀研究項目

宜明昂科-B(01541)：IMM0306治療濾泡性淋巴瘤的III期臨牀試驗申請

港股異動 | 榮昌生物(09995)漲超7% 泰它西普擬納入優先審評品種治療lgA腎病III期研究達成A階段主要終點

康哲藥業(00867)：1類新藥MG-K10人源化單抗注射液新增獲得慢性自發性蕁麻疹適應症藥物III期臨牀試驗批准通知書

關鍵數據公佈！口服司美格魯肽減重III期研究結果出爐

賽諾菲(SNY.US)TSLP/IL-13雙抗啓動COPD II/III期臨牀

泰恩康(301263.SZ)：CKBA乳膏玫瑰痤瘡適應症開展II/III期無縫適應性臨牀試驗

浩歐博(688656.SH)：MM09舌下噴霧劑III期臨牀試驗完成首批受試者入組

針對紅斑狼瘡！阿斯利康首創生物製劑 III 期成功

輝瑞PF-08046054啓動III期臨牀適應症為非小細胞肺癌

港股異動 | 醫渡科技(02158)漲超5% 中標SMR001滴眼液III期臨牀研究項目

醫渡科技(02158)中標重組人神經生長因子(SMR001)滴眼液III期臨牀研究項目

克瑞拓斯安全防衞提拔Brian Shepard為首席信息官

港股異動 | 康諾亞-B(02162)盤中漲超5% 旗下首款雙抗藥物CM336啓動III期研究

歌禮制藥-B(01672)在2025年歐洲皮膚病與性病學會(EADV)年會最新突破性研究專場報告了同類首創脂肪酸合成酶(FASN)抑制劑地尼法司他(ASC40) 治療痤瘡的III期研究結果

研報掘金丨天風證券：維持信立泰「買入」評級，多條管線有望迎來收穫期

國家統計局新聞發言人、總經濟師、國民經濟綜合統計司司長付凌暉在國新辦新聞發佈會上表示民營企業是我國創新發展的「主力軍」。

國家網信辦持續深入整治違規開展互聯網新聞信息服務亂象

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/III/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"III","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"III\",,,,,undefined,":{"symbol":"III","market":"US","secType":"STK","nameCN":"信息服務","latestPrice":5.75,"timestamp":1759262400000,"preClose":5.66,"halted":0,"volume":193477,"hourTrading":{"tag":"盘后","latestPrice":5.64,"preClose":5.75,"latestTime":"19:20 EDT","volume":1543,"amount":8862.1,"timestamp":1759274437565},"delay":0,"floatShares":34233044,"shares":48195469,"eps":0.156933,"marketStatus":"已收盤","change":0.09,"latestTime":"09-30 16:00:00 EDT","open":5.67,"high":5.7776,"low":5.635,"amount":1102100.906853,"amplitude":0.025194,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.156933,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1759305600000},"marketStatusCode":5,"adr":0,"adrRate":0,"listingDate":1171256400000,"exchange":"NASDAQ","adjPreClose":5.66,"dividendRate":0.031304,"preHourTrading":{"tag":"盘前","latestPrice":5.69,"preClose":5.66,"latestTime":"08:00 EDT","volume":21,"amount":119.49990360000001,"timestamp":1759233601195},"postHourTrading":{"tag":"盘后","latestPrice":5.64,"preClose":5.75,"latestTime":"19:20 EDT","volume":1543,"amount":8862.1,"timestamp":1759274437565},"volumeRatio":0.656077,"impliedVol":3.2257,"impliedVolPercentile":0.996},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"III\",,,,,undefined,":{"symbol":"III","floatShares":34233044,"roa":"3.59%","roe":"8.29%","lyrEps":0.058194,"volumeRatio":0.656077,"shares":48195469,"dividePrice":0.18,"high":5.7776,"amplitude":0.025194,"preClose":5.66,"low":5.635,"week52Low":2.95,"pbRate":"2.95","psRate":"1.15","week52High":6.0059,"institutionHeld":0.6397,"latestPrice":5.75,"eps":0.156933,"divideRate":0.031304,"volume":193477,"delay":0,"ttmEps":0.156933,"open":5.67,"prevYearClose":3.34,"prevWeekClose":5.97,"prevMonthClose":5.17,"prevQuarterClose":4.8,"fiveDayClose":5.64,"twentyDayClose":5.16,"sixtyDayClose":5,"earningDate":1759852800000,"earningTime":"盘后"},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/III\",params:#limit:5,,,undefined,":[{"date":"2025-10-08","symbol":"III","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1759953600000,"name":null,"time":"盤後","dateTimestamp":1759896000000,"actualEps":null},{"date":"2025-09-05","symbol":"III","amount":0.045,"announcedDate":"2025-08-06","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-05","defaultRemindTime":1757079000000,"name":"信息服务","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-26","payableDate":"2025-09-05","currency":"USD","dateTimestamp":1757044800000,"payDate":"2025-09-26"},{"market":"US","date":"2025-08-06","symbol":"III","fiscalQuarterEnding":"2025/06","expectedEps":0.05,"name":null,"time":"盤後","type":"earning","dateTimestamp":1754452800000,"reportTimeType":"post","actualEps":0.05},{"date":"2025-06-06","symbol":"III","amount":0.045,"announcedDate":"2025-05-08","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-06","defaultRemindTime":1749216600000,"name":"信息服务","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-27","payableDate":"2025-06-06","currency":"USD","dateTimestamp":1749182400000,"payDate":"2025-06-27"},{"market":"US","date":"2025-05-08","symbol":"III","fiscalQuarterEnding":"2025/03","expectedEps":0.04,"name":null,"time":"盤後","type":"earning","dateTimestamp":1746676800000,"reportTimeType":"post","actualEps":0.04}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"III\",market:\"US\",,,undefined,":[{"executeDate":"2021-06-03","recordDate":"2021-06-04","paymentDate":"2021-06-18","value":0.03,"currency":"USD"},{"executeDate":"2021-09-03","recordDate":"2021-09-07","paymentDate":"2021-09-24","value":0.03,"currency":"USD"},{"executeDate":"2021-12-02","recordDate":"2021-12-03","paymentDate":"2021-12-17","value":0.03,"currency":"USD"},{"executeDate":"2022-03-18","recordDate":"2022-03-21","paymentDate":"2022-04-06","value":0.03,"currency":"USD"},{"executeDate":"2022-06-02","recordDate":"2022-06-03","paymentDate":"2022-06-17","value":0.04,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"III\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.6667,"buy":0.3333,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.6667,"analysts":3,"updateTime":1679457600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/III\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"III","date":"2025-09-29","current":36.63984,"percent":0.83252,"low":-221.876594,"twenty":12.58915,"median":18.866214,"eighty":34.334195,"high":85.733259,"avg":5.250317,"sd":61.532642,"marketCap":287726949},"quantilePoints":[{"date":"2020-10-02","current":32.64723,"twenty":20.050829,"median":32.150556,"eighty":49.624683,"marketCap":100488173},{"date":"2020-10-09","current":33.584471,"twenty":20.050829,"median":32.166915,"eighty":49.624683,"marketCap":103373001},{"date":"2020-10-16","current":32.803437,"twenty":20.050829,"median":32.195146,"eighty":49.624683,"marketCap":100968978},{"date":"2020-10-23","current":32.803437,"twenty":20.050829,"median":32.271873,"eighty":49.624683,"marketCap":100968978},{"date":"2020-10-30","current":32.022403,"twenty":20.050829,"median":32.29645,"eighty":49.624683,"marketCap":98564955},{"date":"2020-11-06","current":37.645849,"twenty":20.050829,"median":32.334816,"eighty":49.624683,"marketCap":115873923},{"date":"2020-11-13","current":37.83975,"twenty":20.050829,"median":32.470567,"eighty":49.624683,"marketCap":128692991},{"date":"2020-11-20","current":37.698557,"twenty":20.050829,"median":32.551135,"eighty":49.624683,"marketCap":128212793},{"date":"2020-11-27","current":45.040598,"twenty":20.050829,"median":32.61356,"eighty":49.624683,"marketCap":153183075},{"date":"2020-12-04","current":44.052247,"twenty":20.055618,"median":32.732778,"eighty":49.624683,"marketCap":149821691},{"date":"2020-12-11","current":44.617019,"twenty":20.096237,"median":32.786479,"eighty":49.624683,"marketCap":151742482},{"date":"2020-12-18","current":46.170143,"twenty":20.444658,"median":32.803437,"eighty":49.624683,"marketCap":157024657},{"date":"2020-12-24","current":42.781509,"twenty":20.563355,"median":32.855737,"eighty":49.624683,"marketCap":145499912},{"date":"2020-12-31","current":46.311336,"twenty":20.775561,"median":32.958394,"eighty":49.624683,"marketCap":157504855},{"date":"2021-01-08","current":49.417585,"twenty":21.565226,"median":33.007951,"eighty":49.624683,"marketCap":168069205},{"date":"2021-01-15","current":55.771274,"twenty":21.971704,"median":33.076029,"eighty":50.098483,"marketCap":189678103},{"date":"2021-01-22","current":50.829515,"twenty":22.396936,"median":33.127057,"eighty":50.207132,"marketCap":172871182},{"date":"2021-01-29","current":49.841164,"twenty":22.679784,"median":33.261363,"eighty":50.440112,"marketCap":169509798},{"date":"2021-02-05","current":52.523833,"twenty":22.936122,"median":33.272057,"eighty":50.716561,"marketCap":178633555},{"date":"2021-02-12","current":52.523833,"twenty":23.262797,"median":33.398429,"eighty":51.059228,"marketCap":178633555},{"date":"2021-02-19","current":53.794571,"twenty":23.609141,"median":33.417527,"eighty":51.276882,"marketCap":182955335},{"date":"2021-02-26","current":51.394288,"twenty":23.816947,"median":33.569725,"eighty":51.732235,"marketCap":174791973},{"date":"2021-03-05","current":53.088605,"twenty":24.140202,"median":33.57217,"eighty":51.962271,"marketCap":180554346},{"date":"2021-03-12","current":77.651845,"twenty":24.664612,"median":33.630766,"eighty":52.202094,"marketCap":213930833},{"date":"2021-03-19","current":71.502943,"twenty":26.272494,"median":33.737549,"eighty":52.523833,"marketCap":196990608},{"date":"2021-03-26","current":76.77343,"twenty":26.854371,"median":33.859576,"eighty":52.626372,"marketCap":211510801},{"date":"2021-04-01","current":78.003211,"twenty":26.956092,"median":33.90293,"eighty":52.747595,"marketCap":214898846},{"date":"2021-04-09","current":75.895016,"twenty":27.210395,"median":33.991802,"eighty":52.906055,"marketCap":209090769},{"date":"2021-04-16","current":76.422065,"twenty":27.379781,"median":34.193624,"eighty":53.109266,"marketCap":210542788},{"date":"2021-04-23","current":77.124796,"twenty":27.464698,"median":34.23369,"eighty":53.271145,"marketCap":212478813},{"date":"2021-04-30","current":79.935723,"twenty":27.596809,"median":34.39907,"eighty":53.663807,"marketCap":220222916},{"date":"2021-05-07","current":85.733259,"twenty":27.758845,"median":34.72983,"eighty":53.929654,"marketCap":236195128},{"date":"2021-05-14","current":34.582604,"twenty":27.90985,"median":34.72983,"eighty":53.929654,"marketCap":260718251},{"date":"2021-05-21","current":37.193814,"twenty":27.984267,"median":34.89521,"eighty":53.929654,"marketCap":280404160},{"date":"2021-05-28","current":37.32119,"twenty":28.127158,"median":35.060591,"eighty":53.929654,"marketCap":281364448},{"date":"2021-06-04","current":35.665301,"twenty":28.201568,"median":35.178625,"eighty":53.929654,"marketCap":268880701},{"date":"2021-06-11","current":36.811685,"twenty":28.275979,"median":35.34686,"eighty":53.929654,"marketCap":277523295},{"date":"2021-06-18","current":35.283172,"twenty":28.317177,"median":35.460054,"eighty":53.929654,"marketCap":265999836},{"date":"2021-06-25","current":35.983741,"twenty":28.42477,"median":35.600769,"eighty":53.929654,"marketCap":271281422},{"date":"2021-07-02","current":38.27651,"twenty":28.559204,"median":35.741483,"eighty":53.929654,"marketCap":288566610},{"date":"2021-07-09","current":38.212822,"twenty":28.661781,"median":35.920053,"eighty":53.929654,"marketCap":288086466},{"date":"2021-07-16","current":36.174805,"twenty":28.841499,"median":36.238493,"eighty":53.929654,"marketCap":272721854},{"date":"2021-07-23","current":38.085446,"twenty":29.02216,"median":36.365869,"eighty":53.929654,"marketCap":287126177},{"date":"2021-07-30","current":38.021758,"twenty":29.112158,"median":36.556933,"eighty":53.929654,"marketCap":286646033},{"date":"2021-08-06","current":37.830694,"twenty":29.227833,"median":36.811685,"eighty":53.929654,"marketCap":285205601},{"date":"2021-08-13","current":30.04792,"twenty":29.342728,"median":36.811685,"eighty":53.929654,"marketCap":331488657},{"date":"2021-08-20","current":29.125396,"twenty":29.392136,"median":36.811685,"eighty":53.929654,"marketCap":321311374},{"date":"2021-08-27","current":31.014374,"twenty":29.446637,"median":36.811685,"eighty":53.929654,"marketCap":342150573},{"date":"2021-09-03","current":32.376195,"twenty":29.490206,"median":36.811685,"eighty":53.929654,"marketCap":357174181},{"date":"2021-09-10","current":33.869805,"twenty":29.540957,"median":36.811685,"eighty":53.929654,"marketCap":373651688},{"date":"2021-09-17","current":33.210859,"twenty":29.540957,"median":36.811685,"eighty":53.929654,"marketCap":366382200},{"date":"2021-09-24","current":32.859422,"twenty":29.540957,"median":36.811685,"eighty":53.929654,"marketCap":362505139},{"date":"2021-10-01","current":31.936898,"twenty":29.540957,"median":36.811685,"eighty":53.929654,"marketCap":352327856},{"date":"2021-10-08","current":33.386578,"twenty":29.603046,"median":36.811685,"eighty":53.929654,"marketCap":368320730},{"date":"2021-10-15","current":31.849038,"twenty":29.673426,"median":36.811685,"eighty":53.929654,"marketCap":351358591},{"date":"2021-10-22","current":33.386578,"twenty":29.768974,"median":36.811685,"eighty":53.929654,"marketCap":368320730},{"date":"2021-10-29","current":35.802712,"twenty":29.76934,"median":36.811685,"eighty":53.929654,"marketCap":394975520},{"date":"2021-11-05","current":32.443868,"twenty":29.838435,"median":36.811685,"eighty":53.929654,"marketCap":434715388},{"date":"2021-11-12","current":34.955794,"twenty":29.845286,"median":36.811685,"eighty":53.929654,"marketCap":468372678},{"date":"2021-11-19","current":34.77297,"twenty":29.845286,"median":36.811685,"eighty":53.929654,"marketCap":465923030},{"date":"2021-11-26","current":30.348649,"twenty":29.845286,"median":36.811685,"eighty":53.929654,"marketCap":406641551},{"date":"2021-12-03","current":28.886064,"twenty":29.82833,"median":36.811685,"eighty":53.929654,"marketCap":387044368},{"date":"2021-12-10","current":29.507663,"twenty":29.768974,"median":36.811685,"eighty":53.929654,"marketCap":395373171},{"date":"2021-12-17","current":26.984703,"twenty":29.661234,"median":36.811685,"eighty":53.929654,"marketCap":361568030},{"date":"2021-12-23","current":28.081642,"twenty":29.603046,"median":36.811685,"eighty":53.929654,"marketCap":376265917},{"date":"2021-12-31","current":27.862254,"twenty":29.504246,"median":36.811685,"eighty":53.929654,"marketCap":373326339},{"date":"2022-01-07","current":26.399668,"twenty":29.437039,"median":36.760945,"eighty":53.927618,"marketCap":353729156},{"date":"2022-01-14","current":25.302729,"twenty":29.255815,"median":36.760945,"eighty":53.927618,"marketCap":339031269},{"date":"2022-01-21","current":23.145416,"twenty":29.125104,"median":36.760945,"eighty":53.927618,"marketCap":310125424},{"date":"2022-01-28","current":22.670075,"twenty":29.042114,"median":36.760945,"eighty":53.927618,"marketCap":303756339},{"date":"2022-02-04","current":24.863954,"twenty":29.042114,"median":36.760945,"eighty":53.927618,"marketCap":333152114},{"date":"2022-02-11","current":25.887763,"twenty":29.042114,"median":36.760945,"eighty":53.927618,"marketCap":346870142},{"date":"2022-02-18","current":27.130961,"twenty":29.042114,"median":36.760945,"eighty":53.927618,"marketCap":363527748},{"date":"2022-02-25","current":26.107151,"twenty":29.042114,"median":36.760945,"eighty":53.927618,"marketCap":349809720},{"date":"2022-03-04","current":27.423478,"twenty":29.042114,"median":36.760945,"eighty":53.927618,"marketCap":367447185},{"date":"2022-03-11","current":22.999463,"twenty":29.042114,"median":36.760945,"eighty":53.927618,"marketCap":357158663},{"date":"2022-03-18","current":22.63323,"twenty":28.930434,"median":36.760945,"eighty":53.927618,"marketCap":351471428},{"date":"2022-03-25","current":21.138876,"twenty":28.720555,"median":36.760945,"eighty":53.927618,"marketCap":328265612},{"date":"2022-04-01","current":21.387935,"twenty":28.563876,"median":36.760945,"eighty":53.927618,"marketCap":332133248},{"date":"2022-04-08","current":20.640759,"twenty":28.47654,"median":36.760945,"eighty":53.927618,"marketCap":320530340},{"date":"2022-04-14","current":20.79642,"twenty":28.362763,"median":36.760945,"eighty":53.927618,"marketCap":322947612},{"date":"2022-04-22","current":19.769052,"twenty":28.214177,"median":36.760945,"eighty":53.927618,"marketCap":306993613},{"date":"2022-04-29","current":19.519993,"twenty":28.004454,"median":36.760945,"eighty":53.927618,"marketCap":303125977},{"date":"2022-05-06","current":18.430361,"twenty":27.931066,"median":36.760945,"eighty":53.927618,"marketCap":286205069},{"date":"2022-05-13","current":17.907825,"twenty":27.846885,"median":36.556933,"eighty":53.927618,"marketCap":305059795},{"date":"2022-05-20","current":17.625134,"twenty":27.555111,"median":36.381032,"eighty":53.927618,"marketCap":300244158},{"date":"2022-05-27","current":18.472496,"twenty":27.379781,"median":36.238493,"eighty":53.927618,"marketCap":314678973},{"date":"2022-06-03","current":18.274778,"twenty":27.167526,"median":36.092994,"eighty":53.927618,"marketCap":311310849},{"date":"2022-06-10","current":16.269354,"twenty":26.614253,"median":35.829538,"eighty":53.927618,"marketCap":277148453},{"date":"2022-06-17","current":16.551809,"twenty":26.372596,"median":35.640231,"eighty":53.822908,"marketCap":281960058},{"date":"2022-06-24","current":17.879343,"twenty":26.107151,"median":35.537925,"eighty":53.79462,"marketCap":304574602},{"date":"2022-07-01","current":19.093895,"twenty":25.975518,"median":35.458953,"eighty":53.271145,"marketCap":325264504},{"date":"2022-07-08","current":19.856521,"twenty":25.412423,"median":35.283172,"eighty":53.041064,"marketCap":338255838},{"date":"2022-07-15","current":19.291613,"twenty":24.849328,"median":35.178625,"eighty":52.906055,"marketCap":328632628},{"date":"2022-07-22","current":20.138975,"twenty":24.08147,"median":35.060591,"eighty":52.665026,"marketCap":343067443},{"date":"2022-07-29","current":21.071074,"twenty":23.209281,"median":34.955794,"eighty":52.523833,"marketCap":358945740},{"date":"2022-08-05","current":21.635982,"twenty":22.947966,"median":34.77297,"eighty":52.322009,"marketCap":368568950},{"date":"2022-08-12","current":16.409925,"twenty":22.628286,"median":34.72983,"eighty":52.322009,"marketCap":293507911},{"date":"2022-08-19","current":16.552576,"twenty":22.371718,"median":34.475053,"eighty":52.322009,"marketCap":296059374},{"date":"2022-08-26","current":16.15211,"twenty":21.544722,"median":34.282985,"eighty":52.322009,"marketCap":288896647},{"date":"2022-09-02","current":14.950714,"twenty":21.183009,"median":34.23369,"eighty":52.322009,"marketCap":267408467},{"date":"2022-09-09","current":14.817225,"twenty":21.074397,"median":34.193624,"eighty":52.322009,"marketCap":265020891},{"date":"2022-09-16","current":14.123085,"twenty":20.842582,"median":34.06831,"eighty":52.322009,"marketCap":252605498},{"date":"2022-09-23","current":12.948386,"twenty":20.628306,"median":33.98562,"eighty":52.322009,"marketCap":231594833},{"date":"2022-09-30","current":12.708107,"twenty":20.189817,"median":33.90293,"eighty":52.322009,"marketCap":227297197},{"date":"2022-10-07","current":12.761502,"twenty":19.975152,"median":33.869805,"eighty":52.322009,"marketCap":228252227},{"date":"2022-10-14","current":12.814898,"twenty":19.650749,"median":33.737549,"eighty":52.322009,"marketCap":229207257},{"date":"2022-10-21","current":13.268758,"twenty":19.370558,"median":33.630766,"eighty":52.322009,"marketCap":237325014},{"date":"2022-10-28","current":14.790528,"twenty":19.172983,"median":33.57217,"eighty":52.322009,"marketCap":264543376},{"date":"2022-11-04","current":11.924698,"twenty":18.940931,"median":33.57217,"eighty":52.322009,"marketCap":226819682},{"date":"2022-11-11","current":14.156908,"twenty":18.67839,"median":33.490051,"eighty":52.100253,"marketCap":269278547},{"date":"2022-11-18","current":14.055967,"twenty":18.383013,"median":33.406789,"eighty":51.591958,"marketCap":267358557},{"date":"2022-11-25","current":13.52603,"twenty":17.941577,"median":33.349337,"eighty":51.184669,"marketCap":257278611},{"date":"2022-12-02","current":13.223208,"twenty":17.811433,"median":33.272057,"eighty":50.857754,"marketCap":251518642},{"date":"2022-12-09","current":12.59233,"twenty":17.329516,"median":33.261363,"eighty":50.482919,"marketCap":239518707},{"date":"2022-12-16","current":11.406279,"twenty":16.879455,"median":33.138265,"eighty":50.207132,"marketCap":216958829},{"date":"2022-12-23","current":11.507219,"twenty":16.612253,"median":33.07907,"eighty":49.781169,"marketCap":218878818},{"date":"2022-12-30","current":11.60816,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":220798808},{"date":"2023-01-06","current":12.264273,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":233278741},{"date":"2023-01-13","current":13.122268,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":249598653},{"date":"2023-01-20","current":12.970857,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":246718668},{"date":"2023-01-27","current":13.122268,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":249598653},{"date":"2023-02-03","current":13.879322,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":263998575},{"date":"2023-02-10","current":13.879322,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":263998575},{"date":"2023-02-17","current":13.677441,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":260158596},{"date":"2023-02-24","current":12.945622,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":246238671},{"date":"2023-03-03","current":13.500795,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":256798614},{"date":"2023-03-10","current":12.166618,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":239998705},{"date":"2023-03-17","current":11.411218,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":225097683},{"date":"2023-03-24","current":12.147425,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":239620114},{"date":"2023-03-31","current":12.490989,"twenty":16.382886,"median":33.063229,"eighty":49.624683,"marketCap":246397249},{"date":"2023-04-06","current":12.294667,"twenty":16.382886,"median":33.063229,"eighty":49.624683,"marketCap":242524601},{"date":"2023-04-14","current":12.687311,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":250269897},{"date":"2023-04-21","current":12.270127,"twenty":16.45538,"median":33.071968,"eighty":49.624683,"marketCap":242040520},{"date":"2023-04-28","current":12.196506,"twenty":16.45538,"median":33.071968,"eighty":49.624683,"marketCap":240588276},{"date":"2023-05-05","current":12.245586,"twenty":16.45538,"median":33.071968,"eighty":49.624683,"marketCap":241556438},{"date":"2023-05-12","current":13.473902,"twenty":16.45538,"median":33.071968,"eighty":49.624683,"marketCap":246397249},{"date":"2023-05-19","current":14.20765,"twenty":16.45538,"median":33.071968,"eighty":49.624683,"marketCap":259815303},{"date":"2023-05-26","current":13.413927,"twenty":16.45538,"median":33.071968,"eighty":49.624683,"marketCap":245300481},{"date":"2023-06-02","current":13.387469,"twenty":16.45538,"median":33.071968,"eighty":49.624683,"marketCap":244816654},{"date":"2023-06-09","current":13.943076,"twenty":16.45538,"median":33.071968,"eighty":49.624683,"marketCap":254977029},{"date":"2023-06-16","current":14.075363,"twenty":16.45538,"median":33.071968,"eighty":49.624683,"marketCap":257396166},{"date":"2023-06-23","current":15.080746,"twenty":16.529212,"median":33.076029,"eighty":49.624683,"marketCap":275781606},{"date":"2023-06-30","current":14.154735,"twenty":16.551809,"median":33.076029,"eighty":49.624683,"marketCap":258847648},{"date":"2023-07-07","current":13.810789,"twenty":16.551809,"median":33.076029,"eighty":49.624683,"marketCap":252557892},{"date":"2023-07-14","current":14.260565,"twenty":16.551809,"median":33.076029,"eighty":49.624683,"marketCap":260782957},{"date":"2023-07-21","current":14.048906,"twenty":16.551809,"median":33.076029,"eighty":49.624683,"marketCap":256912338},{"date":"2023-07-28","current":13.387469,"twenty":16.551809,"median":33.076029,"eighty":49.624683,"marketCap":244816654},{"date":"2023-08-04","current":16.278939,"twenty":16.551809,"median":33.076029,"eighty":49.624683,"marketCap":254977029},{"date":"2023-08-11","current":16.275803,"twenty":16.382336,"median":32.997393,"eighty":49.558778,"marketCap":254927904},{"date":"2023-08-18","current":15.376759,"twenty":16.278939,"median":32.930248,"eighty":49.391703,"marketCap":240846172},{"date":"2023-08-25","current":15.40776,"twenty":16.232204,"median":32.835614,"eighty":49.042233,"marketCap":241331749},{"date":"2023-09-01","current":16.120795,"twenty":16.15211,"median":32.803437,"eighty":48.925743,"marketCap":252500019},{"date":"2023-09-08","current":15.035742,"twenty":16.031821,"median":32.75433,"eighty":48.809254,"marketCap":235504825},{"date":"2023-09-15","current":14.446713,"twenty":15.779779,"median":32.64723,"eighty":48.576274,"marketCap":226278863},{"date":"2023-09-22","current":13.733678,"twenty":15.562768,"median":32.609831,"eighty":48.459784,"marketCap":215110593},{"date":"2023-09-29","current":13.423662,"twenty":15.404575,"median":32.491023,"eighty":48.459784,"marketCap":210254823},{"date":"2023-10-06","current":13.950688,"twenty":15.345757,"median":32.431996,"eighty":48.459784,"marketCap":218509632},{"date":"2023-10-13","current":13.361659,"twenty":15.080746,"median":32.334816,"eighty":48.343294,"marketCap":209283669},{"date":"2023-10-20","current":13.051644,"twenty":14.911736,"median":32.178609,"eighty":48.324535,"marketCap":204427900},{"date":"2023-10-27","current":12.77263,"twenty":14.827387,"median":32.156546,"eighty":48.226804,"marketCap":200057707},{"date":"2023-11-03","current":15.032891,"twenty":14.614323,"median":32.100506,"eighty":48.180208,"marketCap":200057707},{"date":"2023-11-10","current":15.314305,"twenty":14.614323,"median":32.044484,"eighty":48.063719,"marketCap":203802770},{"date":"2023-11-17","current":15.975354,"twenty":14.614323,"median":32.022403,"eighty":47.932458,"marketCap":212600012},{"date":"2023-11-24","current":16.048804,"twenty":14.614323,"median":31.943078,"eighty":47.714249,"marketCap":213577483},{"date":"2023-12-01","current":15.27758,"twenty":14.614323,"median":31.841671,"eighty":47.187487,"marketCap":203314034},{"date":"2023-12-08","current":16.673128,"twenty":14.619662,"median":31.750721,"eighty":46.490677,"marketCap":221885989},{"date":"2023-12-15","current":16.673128,"twenty":14.619662,"median":31.53949,"eighty":46.22662,"marketCap":221885989},{"date":"2023-12-22","current":17.407627,"twenty":14.619662,"median":31.467912,"eighty":45.230776,"marketCap":231660702},{"date":"2023-12-29","current":17.554527,"twenty":14.614323,"median":31.234022,"eighty":45.040598,"marketCap":233615645},{"date":"2024-01-05","current":16.673128,"twenty":14.608983,"median":31.080268,"eighty":44.740412,"marketCap":221885989},{"date":"2024-01-12","current":16.452778,"twenty":14.608983,"median":30.97496,"eighty":44.593596,"marketCap":218953575},{"date":"2024-01-19","current":16.269154,"twenty":14.603644,"median":30.818124,"eighty":44.593596,"marketCap":216509897},{"date":"2024-01-26","current":17.554527,"twenty":14.608983,"median":30.62605,"eighty":44.463847,"marketCap":233615645},{"date":"2024-02-02","current":16.820028,"twenty":14.608983,"median":30.523385,"eighty":44.220503,"marketCap":223840932},{"date":"2024-02-09","current":16.122254,"twenty":14.608983,"median":30.418362,"eighty":43.923358,"marketCap":214554954},{"date":"2024-02-16","current":16.305879,"twenty":14.608983,"median":30.260593,"eighty":43.769861,"marketCap":216998633},{"date":"2024-02-23","current":15.608105,"twenty":14.608983,"median":30.141793,"eighty":42.75327,"marketCap":207712655},{"date":"2024-03-01","current":15.901904,"twenty":14.614323,"median":30.092043,"eighty":42.030433,"marketCap":211622540},{"date":"2024-03-08","current":34.784891,"twenty":14.614323,"median":29.930691,"eighty":41.395649,"marketCap":214066219},{"date":"2024-03-15","current":30.710223,"twenty":14.614323,"median":29.930691,"eighty":41.308941,"marketCap":188990710},{"date":"2024-03-22","current":32.281078,"twenty":14.614323,"median":30.092043,"eighty":41.308941,"marketCap":198657754},{"date":"2024-03-28","current":31.652736,"twenty":14.614323,"median":30.092043,"eighty":41.308941,"marketCap":194790936},{"date":"2024-04-05","current":31.966907,"twenty":14.608983,"median":30.092453,"eighty":41.339259,"marketCap":196724345},{"date":"2024-04-12","current":30.238966,"twenty":14.608983,"median":30.167144,"eighty":41.339259,"marketCap":186090597},{"date":"2024-04-19","current":28.589568,"twenty":14.608983,"median":30.167144,"eighty":41.339259,"marketCap":175940200},{"date":"2024-04-26","current":27.411426,"twenty":14.614323,"median":30.165826,"eighty":41.308941,"marketCap":168689917},{"date":"2024-05-03","current":26.39037,"twenty":14.614323,"median":30.165826,"eighty":41.308941,"marketCap":162406339},{"date":"2024-05-10","current":25.919114,"twenty":14.614323,"median":30.117759,"eighty":41.308941,"marketCap":159506226},{"date":"2024-05-17","current":-211.151442,"twenty":14.503289,"median":29.916131,"eighty":41.308941,"marketCap":153295947},{"date":"2024-05-24","current":-211.151442,"twenty":14.319403,"median":29.768426,"eighty":41.308941,"marketCap":153295947},{"date":"2024-05-31","current":-216.514018,"twenty":14.260565,"median":29.603046,"eighty":41.308941,"marketCap":157189177},{"date":"2024-06-07","current":-209.810798,"twenty":14.204967,"median":29.476834,"eighty":41.308941,"marketCap":152322639},{"date":"2024-06-14","current":-212.492085,"twenty":14.156908,"median":29.278446,"eighty":41.339259,"marketCap":154269254},{"date":"2024-06-21","current":-203.777899,"twenty":14.123085,"median":28.941526,"eighty":41.369578,"marketCap":147942755},{"date":"2024-06-28","current":-205.788865,"twenty":14.101821,"median":28.815898,"eighty":41.369578,"marketCap":149402716},{"date":"2024-07-05","current":-205.118543,"twenty":14.061456,"median":28.592041,"eighty":41.369578,"marketCap":148916062},{"date":"2024-07-12","current":-210.48112,"twenty":13.995991,"median":28.46557,"eighty":41.369578,"marketCap":152809293},{"date":"2024-07-15","current":-211.151442,"twenty":13.995991,"median":28.446337,"eighty":41.369578,"marketCap":153295947},{"date":"2024-08-02","current":-221.876594,"twenty":13.965764,"median":28.594514,"eighty":41.395649,"marketCap":161082407},{"date":"2024-08-09","current":-155.153276,"twenty":13.890161,"median":28.447288,"eighty":41.369578,"marketCap":158411495},{"date":"2024-08-16","current":-157.547617,"twenty":13.879322,"median":28.196854,"eighty":41.040322,"marketCap":160856117},{"date":"2024-08-23","current":-158.026486,"twenty":13.823503,"median":28.008512,"eighty":39.690077,"marketCap":161345042},{"date":"2024-08-30","current":-166.167244,"twenty":13.795681,"median":27.935383,"eighty":38.544,"marketCap":169656756},{"date":"2024-09-06","current":-154.195541,"twenty":13.753035,"median":27.569737,"eighty":38.347232,"marketCap":157433647},{"date":"2024-09-13","current":-151.322331,"twenty":13.704502,"median":27.313784,"eighty":38.122137,"marketCap":154500100},{"date":"2024-09-20","current":-156.111013,"twenty":13.672394,"median":27.130961,"eighty":37.980944,"marketCap":159389344},{"date":"2024-09-27","current":-154.195541,"twenty":13.62697,"median":26.595041,"eighty":37.894382,"marketCap":157433647},{"date":"2024-10-04","current":-155.153276,"twenty":13.599214,"median":26.468913,"eighty":37.779744,"marketCap":158411495},{"date":"2024-10-11","current":-150.364595,"twenty":13.553316,"median":26.233285,"eighty":37.589923,"marketCap":153522252},{"date":"2024-10-18","current":-152.280068,"twenty":13.524775,"median":26.107151,"eighty":37.433759,"marketCap":155477949},{"date":"2024-10-25","current":-147.012518,"twenty":13.48942,"median":25.919114,"eighty":37.27024,"marketCap":150099781},{"date":"2024-10-31","current":-150.364595,"twenty":13.450324,"median":25.485552,"eighty":37.015362,"marketCap":153522252},{"date":"2024-11-08","current":-52.964156,"twenty":13.423662,"median":24.845672,"eighty":36.750798,"marketCap":162811815},{"date":"2024-11-15","current":-53.318651,"twenty":13.387469,"median":24.004684,"eighty":36.556933,"marketCap":163901532},{"date":"2024-11-22","current":-53.238832,"twenty":13.341574,"median":23.198637,"eighty":36.327656,"marketCap":163656170},{"date":"2024-11-29","current":-58.905934,"twenty":13.314055,"median":22.981027,"eighty":36.238493,"marketCap":181076842},{"date":"2024-12-06","current":-58.267387,"twenty":13.27171,"median":22.651653,"eighty":35.999189,"marketCap":179113949},{"date":"2024-12-13","current":-58.427024,"twenty":13.239501,"median":22.455197,"eighty":35.783905,"marketCap":179604672},{"date":"2024-12-20","current":-55.074654,"twenty":13.19425,"median":21.621859,"eighty":35.607032,"marketCap":169299486},{"date":"2024-12-27","current":-53.957197,"twenty":13.130069,"median":21.342486,"eighty":35.505726,"marketCap":165864424},{"date":"2025-01-03","current":-51.88192,"twenty":13.070245,"median":21.138876,"eighty":35.459393,"marketCap":159485023},{"date":"2025-01-10","current":-49.96628,"twenty":13.021327,"median":20.901601,"eighty":35.211692,"marketCap":153596345},{"date":"2025-01-17","current":-51.88192,"twenty":12.972548,"median":20.664813,"eighty":35.117714,"marketCap":159485023},{"date":"2025-01-24","current":-51.562647,"twenty":12.952487,"median":20.578494,"eighty":35.032487,"marketCap":158503577},{"date":"2025-01-31","current":-49.168097,"twenty":12.915203,"median":20.138975,"eighty":34.93156,"marketCap":151142730},{"date":"2025-02-07","current":-51.083737,"twenty":12.802486,"median":19.831317,"eighty":34.780123,"marketCap":157031408},{"date":"2025-02-14","current":-51.40301,"twenty":12.725025,"median":19.519993,"eighty":34.72983,"marketCap":158012854},{"date":"2025-02-21","current":-49.48737,"twenty":12.667751,"median":19.333199,"eighty":34.575342,"marketCap":152124176},{"date":"2025-02-28","current":-49.00846,"twenty":12.601316,"median":19.122141,"eighty":34.324158,"marketCap":150652007},{"date":"2025-03-07","current":53.583718,"twenty":12.589786,"median":18.928478,"eighty":34.23369,"marketCap":152124176},{"date":"2025-03-14","current":56.52218,"twenty":12.589786,"median":18.928478,"eighty":34.23369,"marketCap":160466470},{"date":"2025-03-21","current":63.229713,"twenty":12.589786,"median":18.928478,"eighty":34.39907,"marketCap":179509154},{"date":"2025-03-28","current":64.079574,"twenty":12.589786,"median":18.928478,"eighty":34.546571,"marketCap":181921911},{"date":"2025-04-04","current":63.569657,"twenty":12.589786,"median":18.928478,"eighty":34.686729,"marketCap":180474257},{"date":"2025-04-11","current":60.17021,"twenty":12.590422,"median":18.990743,"eighty":34.733776,"marketCap":170823227},{"date":"2025-04-17","current":62.889768,"twenty":12.590422,"median":18.990743,"eighty":34.814432,"marketCap":178544051},{"date":"2025-04-25","current":62.379851,"twenty":12.589786,"median":18.928478,"eighty":34.943677,"marketCap":177096396},{"date":"2025-05-02","current":64.589491,"twenty":12.589786,"median":18.928478,"eighty":34.985212,"marketCap":183369566},{"date":"2025-05-09","current":25.015629,"twenty":12.589786,"median":18.928478,"eighty":35.046539,"marketCap":193020596},{"date":"2025-05-16","current":29.987043,"twenty":12.589786,"median":18.928478,"eighty":34.985212,"marketCap":231380025},{"date":"2025-05-23","current":29.29984,"twenty":12.589786,"median":18.928478,"eighty":34.985212,"marketCap":226077566},{"date":"2025-05-30","current":29.237367,"twenty":12.589786,"median":18.928478,"eighty":34.985212,"marketCap":225595524},{"date":"2025-06-06","current":29.424786,"twenty":12.589786,"median":18.928478,"eighty":34.964732,"marketCap":227041650},{"date":"2025-06-13","current":29.862097,"twenty":12.589786,"median":18.928478,"eighty":34.964732,"marketCap":230415942},{"date":"2025-06-20","current":29.612205,"twenty":12.58915,"median":18.866214,"eighty":34.964732,"marketCap":228487775},{"date":"2025-06-27","current":28.862529,"twenty":12.58915,"median":18.866214,"eighty":34.964732,"marketCap":222703274},{"date":"2025-07-03","current":31.923706,"twenty":12.58915,"median":18.866214,"eighty":34.955794,"marketCap":246323318},{"date":"2025-07-11","current":31.486395,"twenty":12.58915,"median":18.866214,"eighty":34.955794,"marketCap":242949026},{"date":"2025-07-18","current":29.237367,"twenty":12.58915,"median":18.866214,"eighty":34.89521,"marketCap":225595524},{"date":"2025-07-25","current":28.425218,"twenty":12.58915,"median":18.866214,"eighty":34.834126,"marketCap":219328982},{"date":"2025-08-01","current":26.925866,"twenty":12.58915,"median":18.866214,"eighty":34.784891,"marketCap":207759981},{"date":"2025-08-08","current":25.754678,"twenty":12.58915,"median":18.866214,"eighty":34.77297,"marketCap":202457522},{"date":"2025-08-15","current":30.470866,"twenty":12.58915,"median":18.866214,"eighty":34.704469,"marketCap":239531480},{"date":"2025-08-22","current":29.489913,"twenty":12.58915,"median":18.866214,"eighty":34.221243,"marketCap":231820205},{"date":"2025-08-29","current":31.39051,"twenty":12.58915,"median":18.866214,"eighty":34.114807,"marketCap":246760801},{"date":"2025-09-05","current":32.432773,"twenty":12.58915,"median":18.85295,"eighty":34.118522,"marketCap":254954031},{"date":"2025-09-12","current":32.126225,"twenty":12.58915,"median":18.866214,"eighty":34.114807,"marketCap":252544257},{"date":"2025-09-19","current":33.965513,"twenty":12.58915,"median":18.866214,"eighty":34.114807,"marketCap":267002898},{"date":"2025-09-26","current":35.314324,"twenty":12.58915,"median":18.866214,"eighty":34.309102,"marketCap":277605901},{"date":"2025-09-29","current":36.601825,"twenty":12.58915,"median":18.866214,"eighty":34.334195,"marketCap":287726949}],"updateTime":1759278837738},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"III\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2571328081","title":"新股消息 | 濱會生物遞表港交所 已將BS001推進至中國黑色素瘤III期臨牀試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=2571328081","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571328081?lang=zh_tw&edition=fundamental","pubTime":"2025-09-30 21:11","pubTimestamp":1759237891,"startTime":"0","endTime":"0","summary":"滨会生物的BS001为全球首个达到临床阶段并进入 III期关键试验的以HSV-2为病毒骨架的溶瘤病毒候选药物，有潜力成为全球首个获批准的以HSV-2为病毒骨架的溶瘤病毒疗法。BS001亦为首个获药品审评中心授予突破性疗法认定的溶瘤病毒候选药物。公司已将BS001推进至中国黑色素瘤III期临床试验，该试验为随机控制试验，显著采用主管监管机关认可的肿瘤学黄金标准疗效终点总生存期作为主要终点。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1351513.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4134","III","HEXmain"],"gpt_icon":0},{"id":"2571103383","title":"銀諾醫藥-B(02591)已在中國完成核心產品(即依蘇帕格魯肽α)用於治療肥胖和超重的III期臨牀試驗的首例患者給藥","url":"https://stock-news.laohu8.com/highlight/detail?id=2571103383","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571103383?lang=zh_tw&edition=fundamental","pubTime":"2025-09-30 17:05","pubTimestamp":1759223106,"startTime":"0","endTime":"0","summary":"智通财经APP讯，银诺医药-B(02591)发布公告，于2025年9月30日，公司已在中国完成核心产品(即依苏帕格鲁肽α)用于治疗肥胖和超重的III期临床试验的首例患者给药。公司计划就该临床试验招募大约800位参与者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1351279.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4134","III","BK1161","02591"],"gpt_icon":0},{"id":"2571110643","title":"港股異動 | 醫渡科技(02158)漲超14% AI有望賦能臨牀試驗 附屬中標SMR001滴眼液III期臨牀研究項目","url":"https://stock-news.laohu8.com/highlight/detail?id=2571110643","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571110643?lang=zh_tw&edition=fundamental","pubTime":"2025-09-30 16:00","pubTimestamp":1759219204,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，医渡科技(02158)尾盘涨超14%，截至发稿，涨12.89%，报6.57港元，成交额4.66亿港元。消息面上，医渡科技近期公布，公司联属公司天津开心生活科技有限公司中标山东衍渡生物科技有限公司重组人神经生长因子(SMR001)滴眼液Ⅲ期临床研究项目，项目总金额约为人民币5582万元。值得注意的是，9月16日，2025腾讯数字生态大会医疗专场召开。医渡科技高级解决方案专家施成发表“AI赋能临床试验全流程”主题演讲，结合医渡科技多年技术沉淀与实践案例，从技术支撑、场景落地到生态构建，全面阐释了AI切实提升临床试验效率与质量的路径，推动行业高质量发展。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1351206.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1518","BK1617","HSCEI","BK4134","III","02158","BK4614","BK1189","YANG"],"gpt_icon":0},{"id":"2571305263","title":"宜明昂科-B(01541)：IMM0306治療濾泡性淋巴瘤的III期臨牀試驗申請","url":"https://stock-news.laohu8.com/highlight/detail?id=2571305263","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571305263?lang=zh_tw&edition=fundamental","pubTime":"2025-09-29 22:58","pubTimestamp":1759157916,"startTime":"0","endTime":"0","summary":"智通财经APP讯，宜明昂科-B 发布公告，本集团已向中国国家药品监督管理局药品审评中心提交IMM0306 III期临床试验的申请。由本集团独立研发的IMM0306是一种靶向分化簇47及分化簇20的双特异性分子，是全球首个进入临床阶段的CD47和CD20双靶向双特异性分子。截至本公告日期，本集团拥有IMM0306的全球知识产权及商业化权利。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1350948.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4134","III","BK1161","01541"],"gpt_icon":0},{"id":"2571872763","title":"港股異動 | 榮昌生物(09995)漲超7% 泰它西普擬納入優先審評品種 治療lgA腎病III期研究達成A階段主要終點","url":"https://stock-news.laohu8.com/highlight/detail?id=2571872763","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571872763?lang=zh_tw&edition=fundamental","pubTime":"2025-09-29 11:01","pubTimestamp":1759114882,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，荣昌生物涨超7%，截至发稿，涨7.25%，报109.4港元，成交额3.57亿港元。消息面上，9月28日，CDE官网显示，荣昌生物泰它西普拟纳入优先审评品种，用于治疗具有进展风险的原发性免疫球蛋白 A肾病成人患者，显著降低蛋白尿水平。此前8月27日，荣昌生物宣布泰它西普治疗lgA肾病的国内III期研究达成A阶段的主要终点。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1350449.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1064131003.USD","YANG","09995","BK4134","BK1161","LU2328871848.SGD","HSCEI","BK4614","III","LU2148510915.USD","BK1574","BK0239","688331","BK1583","LU1064130708.USD","LU1969619763.USD","LU2488822045.USD"],"gpt_icon":0},{"id":"2570844305","title":"康哲藥業(00867)：1類新藥MG-K10人源化單抗注射液新增獲得慢性自發性蕁麻疹適應症藥物III期臨牀試驗批准通知書","url":"https://stock-news.laohu8.com/highlight/detail?id=2570844305","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570844305?lang=zh_tw&edition=fundamental","pubTime":"2025-09-28 19:51","pubTimestamp":1759060312,"startTime":"0","endTime":"0","summary":"产品的嗜酸性粒细胞性食管炎、慢性鼻窦炎伴鼻息肉适应症也已获得NMPA签发的药物临床试验批准通知书。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1350344.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE00BVYPNP33.GBP","MG","00867","LU2488822045.USD","IE0031619046.USD","BK1593","BK4123","BK4134","IE00B7SZL793.SGD","IE00BMCWC346.EUR","III","SG9999015978.USD","IE00B19Z4B17.USD","IE00B66KJ199.SGD","IE00BVYPNQ40.USD","BK1191","SG9999015952.SGD","IE00BGHQDM52.EUR","IE00BYV24P56.USD","SG9999015945.SGD","SG9999004220.SGD","SG9999015986.USD"],"gpt_icon":0},{"id":"2570849341","title":"關鍵數據公佈！口服司美格魯肽減重III期研究結果出爐","url":"https://stock-news.laohu8.com/highlight/detail?id=2570849341","media":"医药地理","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570849341?lang=zh_tw&edition=fundamental","pubTime":"2025-09-28 17:09","pubTimestamp":1759050592,"startTime":"0","endTime":"0","summary":"诺和诺德近日公布口服司美格鲁肽III期研究数据，治疗64周后患者平均体重下降16.6%，超三分之一用药者减重超20%，疗效与注射剂型相当。礼来口服替尔泊肽也于早前披露类似积极结果，36mg剂量组患者平均减重7.3kg。目前GLP-1类减重药物市场呈现高速增长态势。2025年上半年，诺和诺德司美格鲁肽减重版全球销售额同比增长78%，礼来替尔泊肽减重版增速更高达223%，远超过其降糖版产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250928181749a449e67d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250928181749a449e67d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4599","III","LU1093756325.SGD","LU1093756168.USD","LU0154236417.USD","BK4007","BK4134","BK4585","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","BK4532","NVO"],"gpt_icon":1},{"id":"2570302992","title":"賽諾菲(SNY.US)TSLP/IL-13雙抗啓動COPD II/III期臨牀","url":"https://stock-news.laohu8.com/highlight/detail?id=2570302992","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570302992?lang=zh_tw&edition=fundamental","pubTime":"2025-09-26 09:05","pubTimestamp":1758848759,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，9月24日，全球临床试验收录网站显示，赛诺菲的TSLP/IL-13双抗Lunsekimig推进至II/III期阶段，针对慢性阻塞性肺病启动了两项II/III期临床试验。研究的主要终点为基线至第48周中重度COPD恶化的年化发生率。此前，赛诺菲曾公布Lunsekimig治疗哮喘的Ib期概念验证研究数据。数据显示，哮喘患者经400mg Lunsekimig治疗28天后，呼出一氧化碳分数较基线显著降低，较安慰剂组降幅为40.9ppb。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1349691.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["III","TSLP","SNY","BK4585","BK4588","BK4007","BK4134","IE00BFXG1179.USD"],"gpt_icon":0},{"id":"2570067200","title":"泰恩康(301263.SZ)：CKBA乳膏玫瑰痤瘡適應症開展II/III期無縫適應性臨牀試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=2570067200","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570067200?lang=zh_tw&edition=fundamental","pubTime":"2025-09-25 17:15","pubTimestamp":1758791702,"startTime":"0","endTime":"0","summary":"智通财经APP讯，泰恩康(301263.SZ)公告，公司控股子公司江苏博创园生物医药科技有限公司(简称“博创园”)收到国家药品监督管理局签发的《药物临床试验批准通知书》，同意CKBA乳膏玫瑰痤疮适应症开展II/III期无缝适应性临床试验。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1349378.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4134","301263","BK0250","III"],"gpt_icon":0},{"id":"2569241705","title":"浩歐博(688656.SH)：MM09舌下噴霧劑III期臨牀試驗完成首批受試者入組","url":"https://stock-news.laohu8.com/highlight/detail?id=2569241705","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569241705?lang=zh_tw&edition=fundamental","pubTime":"2025-09-24 19:34","pubTimestamp":1758713667,"startTime":"0","endTime":"0","summary":"近日，公司收到全资子公司上海浩欧博生物医药有限责任公司通知，由上海浩欧博与Inmunotek公司联合申报的脱敏药MM09舌下喷雾剂III期临床试验成功完成首批受试者入组给药。此外，依托广东省药品监督管理局“港澳药械通”政策支持，猫毛、狗毛及屋尘螨/粉尘螨三款单品已顺利获得“粤港澳大湾区内地临床急需进口港澳药品批件”。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1349027.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688656","BK4134","BK0239","III"],"gpt_icon":0},{"id":"2570835096","title":"針對紅斑狼瘡！阿斯利康首創生物製劑 III 期成功","url":"https://stock-news.laohu8.com/highlight/detail?id=2570835096","media":"新浪医药","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570835096?lang=zh_tw&edition=fundamental","pubTime":"2025-09-24 19:26","pubTimestamp":1758713200,"startTime":"0","endTime":"0","summary":"9 月 17 日，阿斯利康宣布，其皮下注射首创生物制剂Saphnelo针对系统性红斑狼疮患者 III 期 TULIP-SC 试验的预定中期分析达到主要终点。截至2025年9月，红斑狼疮领域已有多个新药获批上市，同时也有多个潜力药物处于临床III期或关键II期阶段。2024年7月16日，葛兰素史克生产研发的全球首个治疗系统性红斑狼疮生物制剂注射用贝利尤单抗获得国家药品监督管理局批准在中国内地上市。2023年3月，荣昌生物的泰它西普获批上市，用于治疗系统性红斑狼疮。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250924193624a441026d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250924193624a441026d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2456880835.USD","BK4134","BK4568","BK4585","LU1829250122.USD","III","LU2462157665.USD","LU0109394709.USD","BK4007","AZN","LU0889565916.HKD","LU2417539215.USD","LU0320765992.SGD","LU2236285917.USD","BK4588"],"gpt_icon":0},{"id":"2569070053","title":"輝瑞PF-08046054啓動III期臨牀 適應症為非小細胞肺癌","url":"https://stock-news.laohu8.com/highlight/detail?id=2569070053","media":"新浪财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569070053?lang=zh_tw&edition=fundamental","pubTime":"2025-09-24 12:31","pubTimestamp":1758688260,"startTime":"0","endTime":"0","summary":"药物临床试验登记与信息公示平台数据显示，Pfizer Inc./辉瑞投资有限公司/BSP Pharmaceuticals S.p.A的一项在既往接受过治疗的程序性细胞死亡配体1  阳性非小细胞肺癌 成人研究参与者中评价PF - 08046054/SGN - PDL1V相比多西他赛的随机、III期、开放性研究已启动。本次试验主要目的为在特定NSCLC研究参与者中，确定PF - 08046054单药治疗与标准治疗多西他赛单药治疗相比是否可改善临床结局。PF - 08046054为生物制品，适应症为非小细胞肺癌。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025092412382897a63026&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025092412382897a63026&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999003800.SGD","SG9999001176.USD","LU1066051498.USD","BK4134","BK4534","BK4533","LU0170899867.USD","PFE","LU0321505439.SGD","IE00B19Z3B42.SGD","LU0321505868.SGD","IE0002270589.USD","BK4599","III","LU0225284248.USD","SG9999001176.SGD","BK4550","LU0289739699.SGD","IE00B19Z3581.USD","LU0234572021.USD","LU0456855351.SGD","LU1066053197.SGD","SG9999013999.USD","LU1023059063.AUD","LU0306807586.USD","SGXZ57979304.SGD","LU0306806265.USD","SG9999002232.USD","IE00BBT3K403.USD","BK4007","IE000M9KFDE8.USD","LU0058720904.USD","LU1883839398.USD","LU0225771236.USD","LU0985481810.HKD","LU1894683348.USD","LU0122379950.USD","BK4568","BK4585","IE00BLSP4239.USD","LU1057294990.SGD","BK4581","SG9999011175.SGD","LU0868494617.USD","LU1894683264.USD","SG9999002224.SGD","IE00BLSP4452.SGD","BK4592","BK4588"],"gpt_icon":1},{"id":"2569721315","title":"港股異動 | 醫渡科技(02158)漲超5% 中標SMR001滴眼液III期臨牀研究項目","url":"https://stock-news.laohu8.com/highlight/detail?id=2569721315","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569721315?lang=zh_tw&edition=fundamental","pubTime":"2025-09-24 11:37","pubTimestamp":1758685044,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，医渡科技(02158)涨超5%，截至发稿，涨5.39%，报6.06港元，成交额7497.34万港元。消息面上，医渡科技公布，近期，公司联属公司天津开心生活科技有限公司中标山东衍渡生物科技有限公司重组人神经生长因子(SMR001)滴眼液Ⅲ期临床研究项目，项目总金额约为人民币5582万元。医渡科技作为中国AI医疗变革驱动者，基于自主研发的核心算法引擎YiduCore，构建“数据—算法—场景”飞轮闭环，实现了AI技术的高效率创新、低成本规模化应用，推动智能决策赋能“医—药—险—患者”全产业链生态。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1348804.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1189","BK4614","YANG","02158","BK1518","III","BK4134","BK1617","HSCEI"],"gpt_icon":0},{"id":"2569765301","title":"醫渡科技(02158)中標重組人神經生長因子(SMR001)滴眼液III期臨牀研究項目","url":"https://stock-news.laohu8.com/highlight/detail?id=2569765301","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569765301?lang=zh_tw&edition=fundamental","pubTime":"2025-09-23 12:08","pubTimestamp":1758600536,"startTime":"0","endTime":"0","summary":"智通财经APP讯，医渡科技 发布公告，近期，公司的联属公司天津开心生活科技有限公司中标山东衍渡生物科技有限公司重组人神经生长因子滴眼液III期临床研究项目，项目总金额约为人民币5581.76万元。AI医疗的核心是通过提升医学证据质量与生成效率，优化研发、诊断及治疗流程，最终实现更安全、更优质、更可及的医疗服务。医疗AI的价值，体现在对每一个个体生命的尊重与对健康福祉的守护。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1348342.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["III","02158","BK4134","BK1617","BK1518","BK1189"],"gpt_icon":0},{"id":"1143211286","title":"克瑞拓斯安全防衞提拔Brian Shepard為首席信息官","url":"https://stock-news.laohu8.com/highlight/detail?id=1143211286","media":"投资观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143211286?lang=zh_tw&edition=fundamental","pubTime":"2025-09-23 04:03","pubTimestamp":1758571425,"startTime":"0","endTime":"0","summary":"圣地亚哥，2025年9月22日——克瑞拓斯安全防卫公司是一家专注于国防、国家安全和全球市场的技术公司，今日宣布任命Brian Shepard为公司首席信息官。作为首席信息官，Shepard先生将负责公司所有信息技术工作，包括信息安全、信息合规和数据通信。克瑞拓斯安全防卫首席信息官Brian Shepard说：\"在克瑞拓斯安全防卫近20年后，我很荣幸能够担任首席信息官这一职务。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4603","III","BK4187","KTOS","BK4134"],"gpt_icon":0},{"id":"2569272349","title":"港股異動 | 康諾亞-B(02162)盤中漲超5% 旗下首款雙抗藥物CM336啓動III期研究","url":"https://stock-news.laohu8.com/highlight/detail?id=2569272349","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569272349?lang=zh_tw&edition=fundamental","pubTime":"2025-09-22 10:18","pubTimestamp":1758507535,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，康诺亚-B盘中涨超5%，截至发稿，涨4.58%，报75.4港元，成交额8753万港元。消息面上，据医药魔方Info报道，9月18日，全球临床试验收录网站显示，康诺亚的CM336启动了首个III期研究。该药物是康诺亚旗下首款进入III期阶段的双抗药物。此前，CM336已完成一项针对R/R MM的I/II期研究。在剂量递增队列中，23例患者可评估疗效。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1347755.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["III","HSCEI","BK1587","BK4614","BK1574","BK1161","BK4134","02162","BK1583","YANG"],"gpt_icon":1},{"id":"2568443560","title":"歌禮制藥-B(01672)在2025年歐洲皮膚病與性病學會(EADV)年會最新突破性研究專場報告了同類首創脂肪酸合成酶(FASN)抑制劑地尼法司他(ASC40) 治療痤瘡的III期研究結果","url":"https://stock-news.laohu8.com/highlight/detail?id=2568443560","media":"智通财经","labels":["conferences","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568443560?lang=zh_tw&edition=fundamental","pubTime":"2025-09-18 07:34","pubTimestamp":1758152079,"startTime":"0","endTime":"0","summary":"智通财经APP讯，歌礼制药-B 发布公告，在2025年9月17日于法国巴黎举行的2025年欧洲皮肤病与性病学会年会最新突破性研究专场上口头报告了地尼法司他治疗中重度寻常性痤疮的III期研究 结果。歌礼计划在完成上市申请前沟通后向NMPA提交地尼法司他用于治疗中重度寻常性痤疮的新药上市申请 。歌礼已从Sagimet Biosciences Inc.获得地尼法司他 的大中华区独家授权。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1346550.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4134","01477","BK1191","III","BK1515","BK1574","BK1161","01672"],"gpt_icon":0},{"id":"2567199258","title":"研報掘金丨天風證券：維持信立泰「買入」評級，多條管線有望迎來收穫期","url":"https://stock-news.laohu8.com/highlight/detail?id=2567199258","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567199258?lang=zh_tw&edition=fundamental","pubTime":"2025-09-15 15:40","pubTimestamp":1757922027,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["159839","BK4017","BK4134","LU1223082196.USD","BK0188","LU1223082519.USD","002294","BK0276","601162","BK0196","LU1223083913.SGD","BK0183","CDE","III","BK0028","BK0187","BK0239"],"gpt_icon":0},{"id":"2567622091","title":"國家統計局新聞發言人、總經濟師、國民經濟綜合統計司司長付凌暉在國新辦新聞發佈會上表示民營企業是我國創新發展的「主力軍」。","url":"https://stock-news.laohu8.com/highlight/detail?id=2567622091","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567622091?lang=zh_tw&edition=fundamental","pubTime":"2025-09-15 11:22","pubTimestamp":1757906532,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4134","III"],"gpt_icon":0},{"id":"2567833184","title":"國家網信辦持續深入整治違規開展互聯網新聞信息服務亂象","url":"https://stock-news.laohu8.com/highlight/detail?id=2567833184","media":"南宁发布","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567833184?lang=zh_tw&edition=fundamental","pubTime":"2025-09-13 16:52","pubTimestamp":1757753520,"startTime":"0","endTime":"0","summary":"某文化传媒有限公司未取得互联网新闻信息服务许可，在微信、微博等平台注册“了新社”矩阵账号，以“通讯员”“记者”名义进行新闻采访报道，违规开展互联网新闻信息采编发布服务。网信部门将持续加大违规开展互联网新闻信息服务乱象整治力度，依法从严处置问题突出的平台和账号，大力营造清朗网络空间。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2025-09-13/doc-infqivsm6732900.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["III","160636","BK4134","159792"],"gpt_icon":0}],"pageSize":20,"totalPage":9,"pageCount":1,"totalSize":168,"code":"91000000","status":"200"}]}}